Literature DB >> 1694325

Schizophrenia: the cellular biology of a functional psychosis.

G W Roberts1.   

Abstract

Structural abnormalities are found in the brains of schizophrenics. They affect preferentially, but not exclusively, medial temporal lobe structures (parahippocampal gyrus, hippocampus and amygdala), and can be found in all sub-types of schizophrenia. The structures of the medial temporal lobe are believed to have a crucial role in the integration and processing of the output from association cortex. It is probable that all schizophrenics have abnormalities in the medial temporal lobe that differ in degree but not in kind. Dysfunction of this system could result in the clinical symptoms that form the core of the schizophrenia syndrome. The changes in brain structure are not the result of neurodegenerative processes or destructive lesions but suggest a disturbance in the normal pattern of brain development.

Entities:  

Mesh:

Year:  1990        PMID: 1694325     DOI: 10.1016/0166-2236(90)90161-3

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  11 in total

1.  Evidence for altered hippocampal function in a mouse model of the human 22q11.2 microdeletion.

Authors:  Liam J Drew; Kimberly L Stark; Karine Fénelon; Maria Karayiorgou; Amy B Macdermott; Joseph A Gogos
Journal:  Mol Cell Neurosci       Date:  2011-05-24       Impact factor: 4.314

2.  Localization of D1 dopamine receptor mRNA in brain supports a role in cognitive, affective, and neuroendocrine aspects of dopaminergic neurotransmission.

Authors:  R T Fremeau; G E Duncan; M G Fornaretto; A Dearry; J A Gingrich; G R Breese; M G Caron
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

Review 3.  Structural and functional brain imaging in schizophrenia.

Authors:  J M Cleghorn; R B Zipursky; S J List
Journal:  J Psychiatry Neurosci       Date:  1991-07       Impact factor: 6.186

4.  Hippocampal morphometry in schizophrenia by high dimensional brain mapping.

Authors:  J G Csernansky; S Joshi; L Wang; J W Haller; M Gado; J P Miller; U Grenander; M I Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

Review 5.  Prefrontal cortical dopamine systems and the elaboration of functional corticostriatal circuits: implications for schizophrenia and Parkinson's disease.

Authors:  A Y Deutch
Journal:  J Neural Transm Gen Sect       Date:  1993

6.  Association of atrophy of the medial temporal lobe with reduced blood flow in the posterior parietotemporal cortex in patients with a clinical and pathological diagnosis of Alzheimer's disease.

Authors:  K A Jobst; A D Smith; C S Barker; A Wear; E M King; A Smith; P A Anslow; A J Molyneux; B J Shepstone; N Soper
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

7.  Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia.

Authors:  N I Perrone-Bizzozero; A C Sower; E D Bird; L I Benowitz; K J Ivins; R L Neve
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

Review 8.  Neural cell adhesion molecule (NCAM) as a quantitative marker in synaptic remodeling.

Authors:  O S Jørgensen
Journal:  Neurochem Res       Date:  1995-05       Impact factor: 3.996

9.  Performance on luria-nebraska neuropsychological battery in schhizophrenic patients.

Authors:  A Nizamie; H S Nizamie; T R Shukla
Journal:  Indian J Psychiatry       Date:  1992-10       Impact factor: 1.759

10.  Hippocampal benzodiazepine receptors in schizophrenia.

Authors:  G P Reynolds; D Stroud
Journal:  J Neural Transm Gen Sect       Date:  1993
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.